🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 17 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
14/02/2008 24,30 25,20 23,50 23,50 -2,08% 7,00% 16.060
13/02/2008 24,20 25,89 23,60 24,00 +1,27% 9,46% 37.040
12/02/2008 26,00 26,80 23,50 23,70 -8,14% 12,69% 32.000
11/02/2008 25,50 27,00 25,10 25,80 +4,03% 7,45% 13.640
08/02/2008 25,90 27,90 24,50 24,80 -4,25% 13,13% 44.100
07/02/2008 26,70 27,70 25,50 25,90 -3,72% 8,24% 14.090
06/02/2008 28,70 28,70 26,30 26,90 -3,58% 8,36% 14.310
05/02/2008 28,50 28,90 27,10 27,90 -4,12% 6,32% 11.180
04/02/2008 30,70 30,70 28,33 29,10 -5,21% 7,72% 10.530
01/02/2008 31,80 32,30 30,20 30,70 -2,23% 6,60% 10.840
31/01/2008 32,00 33,50 31,30 31,40 -2,18% 6,88% 17.480
30/01/2008 31,50 33,50 30,30 32,10 +3,22% 10,16% 16.540
29/01/2008 28,90 31,50 27,60 31,10 +11,07% 13,49% 16.140
28/01/2008 26,30 28,90 26,00 28,00 +7,28% 11,03% 23.910
25/01/2008 28,20 28,80 26,00 26,10 -5,78% 9,93% 15.510
24/01/2008 25,50 28,40 25,50 27,70 +9,06% 11,37% 17.100
23/01/2008 27,10 27,20 23,10 25,40 -6,62% 15,13% 43.890
22/01/2008 29,00 30,00 27,20 27,20 -5,23% 9,66% 31.670
18/01/2008 29,20 32,00 28,50 28,70 -6,51% 11,99% 24.270
17/01/2008 33,30 33,55 29,80 30,70 -7,53% 11,26% 39.110
16/01/2008 30,60 34,00 30,60 33,20 +8,50% 11,11% 20.970
15/01/2008 31,50 33,40 30,20 30,60 -3,77% 10,16% 23.460
14/01/2008 32,70 33,70 31,50 31,80 +0,32% 6,73% 18.460
11/01/2008 32,90 33,90 31,70 31,70 -3,65% 6,69% 18.000
10/01/2008 33,50 33,80 32,30 32,90 -2,66% 4,48% 30.260
09/01/2008 34,50 34,90 33,00 33,80 -1,17% 5,51% 16.260
08/01/2008 34,40 36,00 34,00 34,20 -0,29% 5,81% 11.350
07/01/2008 34,50 35,60 33,80 34,30 +0,88% 5,22% 11.200
04/01/2008 35,00 37,60 33,80 34,00 -3,41% 10,86% 15.980
03/01/2008 36,20 37,90 35,00 35,20 -0,85% 8,01% 14.150